Navigation Links
Results of Two Phase 3 CAPACITY Studies of Pirfenidone in IPF Presented at American Thoracic Society (ATS)
Date:5/19/2009

ch program focused on small molecules for the treatment of pulmonary disease. The hepatology portfolio includes the HCV protease inhibitor compound ITMN-191 (referred to as R7227 at Roche, its development partner) in Phase 1b, a second-generation HCV protease inhibitor research program, and a research program evaluating new targets in hepatology. For additional information about InterMune and its R&D pipeline, please visit www.intermune.com.

Forward-Looking Statements

This news release contains forward-looking statements within the meaning of section 21E of the Securities Exchange Act of 1934, as amended, that reflect InterMune's judgment and involve risks and uncertainties as of the date of this release, including without limitation the statements related to anticipated product development timelines, the interpretation of the CAPACITY clinical data, including certain exploratory analyses conducted by the Company with respect to such data and the likelihood of regulatory success. All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or information. InterMune's actual results could differ materially from those described in InterMune's forward-looking statements. Pirfenidone failed to achieve statistical significance on the primary endpoint in one of its two pivotal clinical trials and there can be no assurance that the regulatory authorities in either the United States or Europe will grant regulatory approval based upon these data, in combination with the other efficacy analyses and safety results the company currently intends to submit in support of its NDA and MAA filings. Further analyses of the CAPACITY results will be conducted in the future and additional observations may be made whi
'/>"/>

SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine technology :

1. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
2. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
3. BioVex to Report Phase I/II Clinical Trial Results for the Front Line Treatment of Head and Neck Cancer With OncoVEX GM-CSF at the 2009 American Society of Clinical Oncology Meeting
4. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
5. Metabolic Solutions Development Company Announces Preliminary Results from Phase IIa Clinical Trial
6. AlphaVax Announces Promising Results in Melanoma Studies
7. Ongoing Landmark ROADMAP Study Demonstrates Significant Improvement in Blood Pressure Control at One Year, According to Blinded Results
8. BioCryst Provides Peramivir Update and Reports First Quarter 2009 Financial Results
9. Bionovo Announces First Quarter 2009 Highlights and Financial Results
10. Alexza Reports 2009 First Quarter Financial Results and Updates Clinical Pipeline Status
11. ADVENTRX Announces Results From ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2015)... , April 21, 2015  Game-changing ... the latest being the European Commission,s ruling on ... global leader and champion of pharmaceutical supply ... of meeting these mandates and offers several tools ... many countries. From an upcoming webinar in May ...
(Date:4/21/2015)...  IntelliQuit™, the world,s first smartphone breathalyzer for smokers, was selected to present as a finalist ... City on Wednesday April 22.  ... ... ... Thirty percent (30%) of all cardiovascular disease is caused by smoking. ...
(Date:4/21/2015)... , April 21, 2015  The American ... U.S. Food and Drug Administration that the agency,s ... for the last 25 years to protect the ... homeopathic medicines. AAHP, the industry,s trade association, was ... of homeopathic medicines to engage in productive discussions ...
Breaking Medicine Technology:Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 2Frequentz Gives the Global Pharmaceutical Supply Chain a Shoulder to Lean On as They Face Expanding Serialization Requirements 3IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 2IntelliQuit World's First Smartphone Breathalyzer for Smokers to Present to American Heart Association Innovation Investment Forum 3Speakers at FDA Hearing Praise Success of Homeopathic Regulatory Framework 2
... CoMeD – On Friday, May 6, 2011, in Tallahassee, ... regulate vaccines containing mercury in Florida.  The amendment would ... import, administer or distribute any vaccine that contained more ... milliliter for children younger than age 7 or pregnant ...
... BEIJING, May 9, 2011 Saladax Biomedical, Inc., a ... to achieve the promise of personalized medicine for new ... Pacific Rim commercialization team to expand its presence in ... Rim commercialization team include: Yunying ...
Cached Medicine Technology:Florida Legislature Refuses to Limit Mercury in Vaccines 2Florida Legislature Refuses to Limit Mercury in Vaccines 3Saladax Biomedical, Inc. Announces Pacific Rim Commercialization Team in Australia and China 2
(Date:4/21/2015)... Top medical tourism firm, VisitandCare.com, is ... ongoing commitment to providing superior patient experiences. Ojas ... with the best possible experience for a comprehensive range ... , Executives at Ojas Aesthetic Clinic persistently assert that, ... nothing about you, without you — through transparent engagement ...
(Date:4/21/2015)... Angelo’s FabriClean has recently announced that the company ... avail the area rug cleaning services. Area rug cleaning ... equipments, making use of the quick drying technique to ... pressure steam extraction to clean even the most stubborn ... made with delicate fabric. , “Good maintenance and ...
(Date:4/21/2015)... Somerset, NJ & New York, NY (PRWEB) April ... the leading global provider of advanced delivery technologies ... health products, today announced the launch of ADVASEPT™ ... the safe and efficient delivery of injectable medications. ... syringe, combining a safe, convenient and functional container ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 QuickMedical, ... equipment and supplies, now represents Schiller America's ... Monitors, ECGs, Stress Tests, and Vital Signs Monitors, ... in Switzerland, is a global leader in the ... products are developed in close cooperation with the ...
(Date:4/21/2015)... Dallas, Texas (PRWEB) April 21, 2015 ... Global Sodium Citrate Industry is a professional and ... global Sodium Citrate Market with a ... companies included in the sodium citrate market research ... Acid Chemicals, Natural Biological, Cofco Biochemical, Capchem, Lianyungang ...
Breaking Medicine News(10 mins):Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 2Health News:VisitandCare.com Cosmetic Surgery Provider in India Earns Recognition for Patient Satisfaction 3Health News:Angelo’s FabriClean Now Offers Area Rug Cleaning in South Surrey with Complimentary Pick-Up and Delivery 2Health News:Catalent Announces the Expansion of its Advanced, Aseptic, Glass-Free Injectable Platform with New ADVASEPT™ Lock Delivery Technology 2Health News:QuickMedical Launches New Product Line: Schiller America 2Health News:QuickMedical Launches New Product Line: Schiller America 3Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 2Health News:Sodium Citrate Industry Global Key Manufacturers Analysis Report 2015-2020 3
... phase of the illness, study says , , WEDNESDAY, Sept. 12 ... the manic phase of bipolar disorder, and works faster than ... a new study has found. , "One of the problems ... have this long period before they start to work," explained ...
... Chance to Help Make a Difference & Join ... N.C., Sept. 12 This fall, Pink is the color,of ... its,14th anniversary in the battle against Breast Cancer September 20 ... to save lives by,purchasing a new 25% Pink Savings Card. ...
... CDH plans continue to grow in popularity among ... Employees who fear high,out-of-pocket costs aren,t blocking the ... and employers take advantage of,money-saving options as healthcare ... Consulting Worldwide, the global human capital consulting,organization of ...
... prevailing issue in the United States, with millions of ... that Pycnogenol, (pic-noj-en-all), an antioxidant plant extract from the ... in children. The study shows Pycnogenol balances stress hormones, ... of ADHD. , The findings, to be published ...
... the days of Hippocrates, people have known that certain ... researchers have learned that these cyclic recurrences of disease, ... In order to accurately predict when outbreaks of disease ... Elena Naumova, PhD, associate professor in the Department of ...
... LOS GATOS, Calif., Sept. 12 Death may be the ... about. It is usually looked,upon as something to fear -- ... Darlyne intend to tear down the walls. "Triumph" is ... Philip,and Darlyne clarified and expressed their feelings about Darlyne,s,impending death ...
Cached Medicine News:Health News:Tamoxifen Helps Treat Bipolar Disorder 2Health News:Tamoxifen Helps Treat Bipolar Disorder 3Health News:Photo: Tanger Outlet Center Shoppers Nationwide can Choose Pink to Fight Breast Cancer 2Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 2Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 3Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 4Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 5Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 6Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 7Health News:National Survey Shows Employee Fears About Consumer-Driven Health Plans on Decline 8Health News:New study: Pine bark extract reduces ADHD symptoms in children 2Health News:Mathematics might save you a trip to the ER 2Health News:'Triumph' -- Traveling Towards Death: Preparing for a New Life 2
Chin Implants are used for cosmetic augmentation, repairing trauma related injuries and genetic deficiencies. They are inserted through an incision in the mouth below the incisor teeth or through an ...
... The IEC CL40 and FL40 Centrifuge ... safety and versatility to increase your ... a broad array of rotors and ... and microplate applications, the IEC CL40 ...
... CL40 and FL40 Centrifuge Series from ... versatility to increase your productivity in ... array of rotors and accessories for ... applications, the IEC CL40 and FL40 ...
... IEC CL31 Multispeed Series offers unsurpassed ... quiet, compact, 1.2 liter benchtop centrifuge. ... and accessories and high-speed centrifugation capabilities, ... everything you need to meet a ...
Medicine Products: